ANIP logo

ANI Pharmaceuticals (ANIP) Company Overview

Profile

Full Name:

ANI Pharmaceuticals, Inc.

Sector:

Healthcare

Industry:

Drug Manufacturers - Specialty & Generic

Country:

United States

IPO:

May 5, 2000

Indexes:

Not included

Website:

http://www.anipharmaceuticals.com

Description:

ANI Pharmaceuticals, Inc. is a pharmaceutical company. Founded in 2001 in the state of Delaware. The headquarters are located in Baudette, Minnesota. The company's main activities include the development, production, and marketing of branded and prescription pharmaceuticals. A wide range of products produced includes medications used to treat various diseases, including cardiovascular, neurological, endocrine, infectious, gastrointestinal, and dermatological diseases, pain relievers, as well as medications for cancer treatment, hormones, and steroids. The company has three manufacturing facilities and its own laboratories that not only control the quality of the raw materials used but also engage in the development of pharmaceuticals.

Key Details

Price

$59.56

Market Cap

$1.25 B(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$614.38 M(+26.20% YoY)

Annual EPS

-

PE Ratio

-

Annual ROE

-4.32%

Annual Debt To Equity

1.46

Beta

0.94

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Feb 28, 2025

Recent annual earnings:

Feb 28, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Jul 18, 2013

Analyst ratings

Recent major analysts updates

Mar 3, 25 HC Wainwright & Co.
Buy
Dec 11, 24 Leerink Partners
Outperform
Nov 11, 24 HC Wainwright & Co.
Buy
Oct 22, 24 Truist Securities
Hold
Oct 11, 24 Piper Sandler
Overweight
Sep 18, 24 Raymond James
Outperform
Sep 17, 24 HC Wainwright & Co.
Buy
Sep 11, 24 Truist Securities
Hold
Aug 7, 24 HC Wainwright & Co.
Buy
Jun 26, 24 HC Wainwright & Co.
Buy

Screeners with ANIP included

Moving average channel strategy
Stocks below SMA 200
US stocks
Companies with buyback
Most recommended stocks
Stocks below analysts price target
Healthcare sector
All stocks
Small cap stocks
Best performing stocks last 5 years

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$59.56
ANIP price is $59.56

Price All-time High

$450.00
ANIP price is currently -86.76% below its historical high of $450.00

Price Analysts Target

$83.00
ANIP price is currently -28.24% lower than the consensus analysts' forecast

Price Today Change

-2.34%
ANIP price is down -2.34% today

Price YTD Change

+7.74%
ANIP price is up +7.74% since January 1st

Price 3-Year Change

+64.21%
ANIP price is up +64.21% over the past 3 years

Market cap

Market Cap

$1.25 B
ANIP market capitalization is $1.25 billion

Market Cap 3-Year Change

+105.08%
ANIP market capitalization is up +105.08% over the past 3 years

Market Cap All-time High

$1.49 B
ANIP market capitalization is currently -15.72% below its historical high of $1.49 billion

Market Cap Sector Rank

77.37%
ANIP market capitalization is higher than 77.37% of companies in Healthcare sector

Technical

Beta

0.94
ANIP beta is 0.94

200-day SMA

$59.55
ANIP price is currently +0.01% above its 200-day simple moving average

14-day RSI

52.99
ANIP 14-day relative strength index is 52.99

30-day Relative Volume

0.85
ANIP 30-day relative volume is 0.85

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$614.38 M
ANIP annual revenue is $614.38 million

Annual Revenue Analysts Estimate

$767.11 M
ANIP annual revenue is currently -19.91% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

+26.2%
ANIP annual revenue is up +26.2% year-on-year

Annual Revenue Sector Rank

76.07%
ANIP annual revenue is higher than 76.07% of companies in Healthcare sector

Profit

Annual Gross Profit

$364.17 M
ANIP annual gross profit is $364.17 million

Annual Gross Margin

59.27%
ANIP annual gross profit margin is 59.27%

Annual Operating Profit

$2.22 M
ANIP annual operating income is $2.22 million

Annual Operating Margin

0.36%
ANIP annual operating profit margin is 0.36%

Annual Net Income

-$18.52 M
ANIP annual net profit is -$18.52 million

Annual Net Margin

-
ANIP annual net profit margin value is unknown

EPS

Annual EPS

-
ANIP annual earnings per share value is unknown

Annual EPS Analysts Estimate

$1.00
ANIP annual earnings per share is currently equal to the consensus analysts' forecast

Annual EPS 1-Year Change

-
ANIP annual earnings per share 1-year change is unknown

Annual EPS Sector Rank

-
ANIP annual earnings per share is unknown

ROA & ROE

Annual ROA

-1.44%
ANIP annual return on assets is -1.44%

Annual ROE

-4.32%
ANIP annual return on equity is -4.32%

EBIT & EBITDA

Annual EBIT

-$4.61 M
ANIP annual earnings before interest & taxes is -$4.61 million

Annual EBITDA

$65.92 M
ANIP annual EBITDA is $65.92 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
ANIP price to earnings ratio value is unknown

PE Ratio Sector Rank

-
ANIP price to earnings ratio is unknown

PB Ratio

PB Ratio

-6.32
ANIP price to book ratio is -6.32

PB Ratio Sector Rank

3.47%
ANIP price to book ratio is higher than 3.47% of companies in Healthcare sector

PS Ratio

PS Ratio

2.04
ANIP price to sales ratio is 2.04

PS Ratio Sector Rank

40.13%
ANIP price to sales ratio is higher than 40.13% of companies in Healthcare sector

Enterprise value

Enterprise Value

$1.73 B
ANIP enterprise value is $1.73 billion

Enterprise Value Sector Rank

80.03%
ANIP enterprise value is higher than 80.03% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

24.44
ANIP EV/EBITDA is 24.44

EV/EBITDA Sector Rank

93.29%
ANIP EV/EBITDA is higher than 93.29% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

2.72
ANIP annual current ratio is 2.72

Annual Quick Ratio

2.02
ANIP annual quick ratio is 2.02

Leverage

Annual Debt To Equity

1.46
ANIP annual debt to equity ratio is 1.46

Annual Interest Coverage Ratio

-0.26
ANIP annual interest coverage ratio is -0.26

Risk & Stability

Piotroski F-Score

2
ANIP piotroski f-score is 2

Altman Z-Score

1.55
ANIP altman z-score is 1.55

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$1.28 B
ANIP annual total assets is $1.28 billion

Annual Non Current Assets

$756.01 M
ANIP annual long term assets is $756.01 million

Annual Current Assets

$527.68 M
ANIP annual total current assets is $527.68 million

Annual Cash & Cash Equivalents

$144.86 M
ANIP annual cash & cash equivalents is $144.86 million

Equity

Annual Book Value

-$198.14 M
ANIP annual book value is -$198.14 million

Annual Working Capital

$334.00 M
ANIP annual working capital is $334.00 million

Liabilities

Annual Total Liabilities

$855.17 M
ANIP annual total liabilities is $855.17 million

Annual Total Long Term Liabilities

$661.49 M
ANIP annual total long term liabilities is $661.49 million

Annual Current Liabilities

$193.68 M
ANIP annual total current liabilities is $193.68 million

Annual Accounts Payable

$45.66 M
ANIP annual accounts payable is $45.66 million

Debt

Annual Total Debt

$624.09 M
ANIP annual total debt is $624.09 million

Annual Total Debt 1-Year Change

+118.47%
ANIP annual total debt is up +118.47% year-on-year

Annual Long Term Debt

$614.92 M
ANIP annual long term debt is $614.92 million

Annual Short Term Debt

$9.17 M
ANIP annual short term debt is $9.17 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$612.16 M
ANIP annual total expenses is $612.16 million

Annual Operating Expenses

$361.95 M
ANIP annual total operating expenses is $361.95 million

Annual Cost Of Goods Sold

$250.21 M
ANIP annual cost of goods sold is $250.21 million

Annual SGA

$249.64 M
ANIP annual SGA is $249.64 million

Annual D&A

$67.73 M
ANIP annual depreciation & amortization is $67.73 million

Annual Interest Expense

$17.60 M
ANIP annual interest expense is $17.60 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

$64.02 M
ANIP annual cash flow from operations is $64.02 million

Annual CFO 1-Year Change

-46.19%
ANIP annual cash flow from operations is down -46.19% year-on-year

Annual CFI

-$404.72 M
ANIP annual cash flow from investing activities is -$404.72 million

Annual CFI 1-Year Change

-2086.37%
ANIP annual cash flow from investing activities is down -2086.37% year-on-year

Annual CFF

$264.94 M
ANIP annual cash flow from financing activities is $264.94 million

Annual CFF 1-Year Change

+292.87%
ANIP annual cash flow from financing activities is up +292.87% year-on-year

Free CashFlow

Annual FCF

$47.06 M
ANIP annual free cash flow is $47.06 million

Annual FCF 1-Year Change

-53.15%
ANIP annual free cash flow is down -53.15% year-on-year

CAPEX

Annual CAPEX

$16.95 M
ANIP annual capital expenditures is $16.95 million

Annual CAPEX 1-Year Change

-8.42%
ANIP annual capital expenditures is down -8.42% year-on-year

Institutional Ownership

Similar stocks

LQDA logo
Liquidia (LQDA)
ETNB logo
89bio (ETNB)
GPCR logo
Structure Therapeutics (GPCR)
IOVA logo
Iovance Biotherapeutics (IOVA)
AMPH logo
Amphastar Pharmaceuticals (AMPH)
ARDX logo
Ardelyx (ARDX)
OPK logo
OPKO Health (OPK)
INMD logo
InMode (INMD)
ASTH logo
Astrana Health (ASTH)

FAQ

  • What is the ticker symbol for ANI Pharmaceuticals?
  • Does ANI Pharmaceuticals pay dividends?
  • What sector is ANI Pharmaceuticals in?
  • What industry is ANI Pharmaceuticals in?
  • What country is ANI Pharmaceuticals based in?
  • When did ANI Pharmaceuticals go public?
  • Is ANI Pharmaceuticals in the S&P 500?
  • Is ANI Pharmaceuticals in the NASDAQ 100?
  • Is ANI Pharmaceuticals in the Dow Jones?
  • When was ANI Pharmaceuticals's last earnings report?
  • When does ANI Pharmaceuticals report earnings?
  • Should I buy ANI Pharmaceuticals stock now?

What is the ticker symbol for ANI Pharmaceuticals?

The ticker symbol for ANI Pharmaceuticals is NASDAQ:ANIP

Does ANI Pharmaceuticals pay dividends?

No, ANI Pharmaceuticals does not pay dividends

What sector is ANI Pharmaceuticals in?

ANI Pharmaceuticals is in the Healthcare sector

What industry is ANI Pharmaceuticals in?

ANI Pharmaceuticals is in the Drug Manufacturers - Specialty & Generic industry

What country is ANI Pharmaceuticals based in?

ANI Pharmaceuticals is headquartered in United States

When did ANI Pharmaceuticals go public?

ANI Pharmaceuticals's initial public offering (IPO) was on May 5, 2000

Is ANI Pharmaceuticals in the S&P 500?

No, ANI Pharmaceuticals is not included in the S&P 500 index

Is ANI Pharmaceuticals in the NASDAQ 100?

No, ANI Pharmaceuticals is not included in the NASDAQ 100 index

Is ANI Pharmaceuticals in the Dow Jones?

No, ANI Pharmaceuticals is not included in the Dow Jones index

When was ANI Pharmaceuticals's last earnings report?

ANI Pharmaceuticals's most recent earnings report was on Feb 28, 2025

When does ANI Pharmaceuticals report earnings?

The date for ANI Pharmaceuticals's next earnings report has not been announced yet

Should I buy ANI Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions